MX3 Diagnostics, Inc.
Austin, TX
- UEI
- N8PKB5L9AZ49
- CAGE
- 89US9
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 2701 Stratford Dr, Austin, TX 78746, USA
- Website
- mx3diagnostics.com
- Founded
- 2017
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $131,374 |
Contract awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Nelson Laboratories, LLC | Salt Lake City, UT | 541380 Testing Laboratories and Services |
| Johnston, Clifford T | West Lafayette, IN | 541690 Other Scientific and Technical Consulting Services |
| Claros Technologies Inc. | Minneapolis, MN | 333310 Commercial and Service Industry Machinery Manufacturing |
| Platypus Technologies LLC | — | 541713 Research and Development in Nanotechnology |
| Innotech Precision Medicine, Inc. | Boston, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
MX3 Diagnostics, Inc., doing business as MX3 Diagnostics Inc., is a small business entity registered to receive federal contract awards since March 22, 2019. The company specializes in developing innovative technologies related to health and safety, particularly in the areas of mine safety and rapid diagnostic testing. While specific background information about the company is not provided, their federal contract history suggests they focus on research and development of advanced diagnostic tools and safety technologies. MX3 Diagnostics has demonstrated capabilities in creating solutions for both civilian and defense agencies, indicating a versatile approach to addressing various government needs.
The company has secured several federal contracts, showcasing its expertise in different areas. Most recently, MX3 Diagnostics was awarded a $131,374 Firm Fixed Price contract by the Centers for Disease Control and Prevention (CDC) for the development and demonstration of mine safety and health technology, with a completion date set for January 30, 2026. This contract supports the CDC's mission of protecting public health and safety in the mining industry. Previously, the company engaged in two Small Business Innovation Research (SBIR) Phase I projects with the Air Force Research Laboratory. One project, awarded in February 2021 for $49,702, focused on developing a rapid sweat test optimized for Air Force personnel. Another SBIR project from December 2019, valued at $49,549, involved creating innovative defense-related dual-purpose technologies with clear Air Force stakeholder needs. Both Air Force contracts were designated as Total Small Business set-asides, highlighting MX3 Diagnostics' status as a small business entity contributing to defense innovation.
Quick answers
Is MX3 Diagnostics, Inc. registered in SAM.gov?
Yes. MX3 Diagnostics, Inc.'s SAM.gov registration is active through July 1, 2027.
How much has MX3 Diagnostics, Inc. received in federal contracts?
Federal contracts obligated $131,374 to MX3 Diagnostics, Inc. in fiscal years 2023 through 2027.
What is MX3 Diagnostics, Inc.'s most recent federal award?
MX3 Diagnostics, Inc.'s most recent federal contract award is Development and demonstration of mine safety and health technology (75D30124C20303), from CDC Pittsburgh, on September 30, 2024.
On GovTribe
See MX3 Diagnostics, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors